Immune-Related Adverse Events Associated with Anti-PD-1/PD-L1 Treatment for Malignancies: A Meta-Analysis

• Main Authors: Peng-Fei Wang (Author), Yang Chen (Author), Si-Ying Song (Author), Ting-Jian Wang (Author), Wen-Jun Ji (Author), Shou-Wei Li (Author), Ning Liu (Author), Chang-Xiang Yan (Author)
• Format: Book
• Published: Frontiers Media S.A., 2017-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Treatment of cancers with programmed cell death protein 1 (PD-1) pathway inhibitors can lead to immune-related adverse events (irAEs), which could be serious and even fetal. Therefore, clinicians should be aware of the characteristics of irAEs associated with the use of such drugs.Method...